Kwabena Ayesu, MD
Internal Medicine · Orlando, FLNPI 1225019284
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,215 of the $1,544 with a category attached, or 78.7%. Every reported general payment came from a single manufacturer, Argenx US, Inc..
Across 10 payments — averaging $154.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$2K
Across 4,006 payments — averaging $6949.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3.9M
- Astrazeneca UK Limited$3.6M
- AbbVie$2.9M
- E.r. Squibb & Sons, L.L.C.$2.4M
- Amgen$2.2M
- Eli Lilly$1.6M
- plus $11.2M from 47 others
What the payments were for
- Travel & lodging$1,21579%
- Food & beverage$32921%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 10 | $1,544 |
How this compares
$1,544 in reported general payments places this provider in the 75th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $9,959 |
| JardianceEmpagliflozin | 11 | $6,377 |
| Pantoprazole Sodium | 19 | $113 |
| Nifedipine ErNifedipine | 11 | $107 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $100 |
| Gabapentin | 14 | $82 |
| Losartan Potassium | 22 | $79 |
| Amlodipine Besylate | 29 | $77 |
| Tamsulosin Hcl | 11 | $75 |
| Atorvastatin Calcium | 24 | $74 |
| Hydralazine Hcl | 11 | $74 |
| Levothyroxine Sodium | 12 | $66 |
| Metoprolol Succinate | 11 | $62 |
| Carvedilol | 20 | $57 |
| Lisinopril | 19 | $55 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Orlando
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.